Mechanical circulatory support in the UK

British Medical Journal

Volumn 334, Issue 7586, 2007, Pages 167-168

  Westaby, Stephen ^a   Poole Wilson, Philip ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ASSISTED CIRCULATION; CARDIOTOXICITY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; COST BENEFIT ANALYSIS; DEFIBRILLATOR; ECONOMIC ASPECT; EDITORIAL; GRAFT SURVIVAL; HEALTH CENTER; HEART FAILURE; HEART MUSCLE INJURY; HEART STROKE VOLUME; HEART TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; MEDICAL EDUCATION; MORTALITY; MULTIPLE ORGAN FAILURE; MYOCARDITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULSATILE FLOW; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION; SURVIVAL; UNITED KINGDOM;

GREAT BRITAIN; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; LONG-TERM CARE;

EID: 33846652283     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39053.636319.2C     Document Type: Editorial

References (12)

1. The National Institute for Health and Clinical Excellence. Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery. London: NICE, 2006.
2. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998;339:1522-33.
3. Frazier OH, Rose AN, McCarthy PM, Burton NA, Tector A, Levin H, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 1995;222:327-8.
4. Zhang J, Narula J. Molecular biology of myocardial recovery. Surg Clin N Am 2004;84:223-42.
5. Hetzer R, Muller J, Weng Y, Wallukat G, Spiegelsberger S, Loebe M, et al. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg 1999;68:742-9.
6. National Institute for Clinical Excellence. The management of chronic heart failure in primary and second care. London: NICE, 2003.
7. Deng MC. Orthotopic heart transplantation: highlights and limitations. Surg Clin North Am 2004;84:243-5.
8. Sharples LD, Buxton MJ, Caine N. Evaluation of the ventricular assist device programme in the United Kingdom. J Heart Lung Transplant 2006;25(suppl 1):80-1.
9. Lee H, Mans B, Taub K, Ghali WA, Dean S, Johnson D, et al. Cost of analysis of ongoing care of patients with end stage renal disease: the impact dialysis modality and dialysis access. Am J Kidney Dis 2002;40:611-22.
10. Rose EA, Gelijns AL, Moskowitz AL, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long term use of left ventricular assist device for end stage heart failure. N Engl J Med 2001;345:435-43.
11. Park SJ, Tector A, Piccioni W, Raines E, Gelijns A, Moskowitz A, et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 2005;129:9-17.
12. Westaby S, Frazier OH, Banning A. Six years of continuous circulatory support. N Engl J Med 2006;355:325-7.